-
Soy Maker Lumen
Foods Warns Mothers Against Using
Its Soymilk
- Press Release
Lumen Foods, a manufacturer of soy-based foods and
beverages, has posted warning labels on its soymilk products in response
to growing research that the high manganese levels found in soy beverages,
and in particular, infant formula, may be neurotoxic to infants under
the age of six months. The labels reads;
"WARNING: Soymilk may be detrimental
to infants under 6 months of age. It contains manganese at
levels important to human nutrition but over 50 times the level
found in mothers breast milk. For more information, see www.soybean.com/h120.htm."
"Our concern is twofold," notes company
president, George Ackerson. "First, that there is mounting
evidence of a correlation between manganese in soymilk (including
soy-based infant formula) and neurotoxicity in small infants, and
secondly, that if we know that credible research exists and we don't
act responsibly, we could be held liable".
Lumen Foods sells a small line of soy beverages
branded "Heaven on Earth", which could conceivably be
used as infant formula. Although the products are competitively
priced against real milk, the company is not a major player in the
retail soy beverage market, and, in fact, most of its soy beverages
sales are made through mail order and institutional accounts.
The company has never sold a distinct line of baby formula.
The company's founder, Greg Caton, made the recommendation
after investigating claims by the Violence Research Foundation (VRF)
of San Clemente, California, that correlates high manganese in soymilk
with brain damage in newborn mammals. In one study, a similar
phenomenon was found in human infants; and in another, by Dr Louis
Gottchalk, elevated manganese levels were found in the scalp hair
of adolescents incarcerated for violent crimes. Separate interviews
by Caton revealed the possibility that soymilk use in small infants
could correlate to the dramatic increases in ADHD (Attention Deficit
Hyperactivity Disorder) and violent adolescent incidents over the
last 40 years.
What is already established is that newborn infants
do not have the ability to metabolize levels of manganese comparable
to human adult capability. This is evidenced by the U.S.
Food & Drug Administration's own recommendations on minimum
daily manganese requirements. Whereas infants are shown to
only require .005 mg. per day; the average adult can readily metabolize
over 1.2 mg. per day, or in excess of 200 times that amount.
Moreover, once stored in neural tissue, excess manganese (and the
effects it exerts) will remain there for many years.
Notes Caton, "My concern,
having spent a month to follow up on the VRF claim and the research
behind it, is that this may be in the one percent category.
We aren't telling people not to drink soymilk. We're just
warning parents to consider that their newborn infants aren't capable
of metabolizing significant levels of one of its mineral nutrients,
and there could be negative consequences to this."
|